Skip to main content
. 2020 Jan;49(1):77–85.

Fig 4:

Fig 4:

Immunoblot analysis of β-catenin with protein extracts from MDA-MB-231 cells treated with 40μM SFN for 24, 48 and 72 h compared with untreated control. (A) A representative original blot, (B) Quantitative data. SFN decreases β-catenin expression in breast cancer cells. Significance was set at *P<0.05